Control IOL: Clinical Trials

2 trials of Control IOL, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable2Completed 2

Follow Control IOL: new trials by email Literature Review of Control IOL trials Research Report on Control IOL

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Light Adjustable lens (LAL) and Light Delivery Device (LDD), Control IOL - Aphakia, Cataract
Not applicableCompletedRxSight, Inc.5002021-12-032025-04-20
Clinical Study to Evaluate the Safety and Effectiveness of the RxSight Light Adjustable Lens (LAL) in Subjects With Prior Corneal Refractive Surgery
Light Adjustable lens (LAL) and Light Delivery Device (LDD), Control IOL - Aphakia, Cataract
Not applicableCompletedRxSight, Inc.1052018-08-282021-12-23

Conditions studied

Aphakia (2)  ·  Cataract (2)

Sponsors

RxSight, Inc. (2)

Countries

United States (2)

Results publications

PMID 41664266, PMID 42302210